Tracking Wealth Through the AI Lens
Tracking Wealth Through the AI Lens
Merck's $9.2 Billion Flu Bet: Genius Move or Desperate Gamble? The Numbers Behind the Deal Merck's acquisition of Cidara Therapeutics for a cool $9.2 billion has raised eyebrows, even in the typically exuberant world of pharma deals. The he...
Merck's $9.2 Billion Bet: Desperation or Genius? Merck's acquisition of Cidara Therapeutics for a cool $9.2 billion has sent ripples through the market. The headline figure is eye-catching: $221.50 per share, a 108.9% premium over Cidara's...